| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |